Experts have said it may take years to contain African swine fever due to the differing biosecurity standards on commercial pig farms and backyard smallholdings across Asia.
Research demonstrated that a naturally occurring fungus engineered to deliver a toxin to mosquitoes safely reduced mosquito populations by more than 99 percent in a simulated village setting in Burkina Faso.
In a new study, remdesivir, an experimental antiviral drug, completely protected four African green monkeys from a lethal dose of Nipah virus,
The US Biomedical Advanced Research and Development Authority (BARDA) will procure Emergent BioSolutions’ anthrax vaccine into the Strategic National Stockpile. The plan is to deliver the vaccine into the Strategic National Stockpile in the second half of 2019.
Researchers at Rochester Clinical Research are helping to test a new smallpox vaccine.
A drone delivery network will distribute medicines, vaccines, and blood, to 2,000 clinics in remote parts of Ghana.
Over the next four years, the experiences of these countries will help the WHO determine if RTS,S can be effectively used, and whether it will deliver the nearly 40 percent decrease in malaria infections seen in an earlier Phase 3 clinical trial.To see whether a new malaria vaccine, RTS, is effective, the World Health Organization (WHO) and partners have devised a limited rollout of the vaccine in Malawi followed by Ghana and Kenya.
At the University of Pennsylvania, researchers and clinicians have been aiming their energy and expertise at Ebola, searching in the lab for drugs to treat it, in the clinic for strategies to safely contain it, and in the field to understand the social and societal factors that bear on it.
The current study investigated the immunogenicity and protective response of rPA antigen formulated with the DPXTM no-release delivery platform (DPX-rPA). This unique formulation promotes a depot effect that attracts antigen-presenting cells to the vaccination site and elicits an immune response following single-dose delivery.
By developing a vaccine that targets specific cells in the immune system, researchers have seen a much greater immune and antibody response to the vaccine.